Related references
Note: Only part of the references are listed.Extracellular vesicles for drug delivery
Pieter Vader et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Genetics and biology of pancreatic ductal adenocarcinoma
Haoqiang Ying et al.
GENES & DEVELOPMENT (2016)
KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment
Daniel Zeitouni et al.
CANCERS (2016)
A rapid, automated surface protein profiling of single circulating exosomes in human blood
Golam Kibria et al.
SCIENTIFIC REPORTS (2016)
Improving Prospects for Targeting RAS
Harshabad Singh et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
Xiaofeng Zheng et al.
NATURE (2015)
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Sonia A. Melo et al.
NATURE (2015)
RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients
Talia Golan et al.
ONCOTARGET (2015)
Active macropinocytosis induction by stimulation of epidermal growth factor receptor and oncogenic Ras expression potentiates cellular uptake efficacy of exosomes
Ikuhiko Nakase et al.
SCIENTIFIC REPORTS (2015)
Oncogenic KRAS signalling in pancreatic cancer
S. Eser et al.
BRITISH JOURNAL OF CANCER (2014)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Berna C. Oezdemir et al.
CANCER CELL (2014)
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis
Sonia A. Melo et al.
CANCER CELL (2014)
Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy
Mara H. Sherman et al.
CELL (2014)
Biogenesis and secretion of exosomes
Joanna Kowal et al.
CURRENT OPINION IN CELL BIOLOGY (2014)
Pancreatic cancer genomics
David K. Chang et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
Extracellular vesicles as drug delivery systems: Lessons from the liposome field
Roy van der Meel et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs
Chad V. Pecot et al.
MOLECULAR CANCER THERAPEUTICS (2014)
CD47-dependent immunomodulatory and angiogenic activities of extracellular vesicles produced by T cells
Sukhbir Kaur et al.
MATRIX BIOLOGY (2014)
Small RNA combination therapy for lung cancer
Wen Xue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Development of siRNA Payloads to Target KRAS-Mutant Cancer
Tina L. Yuan et al.
CANCER DISCOVERY (2014)
Genetically engineered mouse models of pancreatic adenocarcinoma
Carmen Guerra et al.
MOLECULAR ONCOLOGY (2013)
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Cosimo Commisso et al.
NATURE (2013)
Mutant KRAS is a druggable target for pancreatic cancer
Elina Zorde Khvalevsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Lipid-Based Nanoparticles for siRNA Delivery in Cancer Therapy: Paradigms and Challenges
Ligia C. Gomes-da-Silva et al.
ACCOUNTS OF CHEMICAL RESEARCH (2012)
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
Paolo P. Provenzano et al.
CANCER CELL (2012)
Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic Neoplasia
Yuliya Pylayeva-Gupta et al.
CANCER CELL (2012)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
Translational Therapeutic Opportunities in Ductal Adenocarcinoma of the Pancreas
Manuel Hidalgo et al.
CLINICAL CANCER RESEARCH (2012)
The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications
Mark P. Chao et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice
Meredith A. Collins et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Andrew V. Biankin et al.
NATURE (2012)
Exosome-mediated delivery of siRNA in vitro and in vivo
Samir El-Andaloussi et al.
NATURE PROTOCOLS (2012)
Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice
Meredith A. Collins et al.
PLOS ONE (2012)
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B. Willingham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Activated KrasG12D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin
S. Rachagani et al.
BRITISH JOURNAL OF CANCER (2011)
Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma
Hideaki Ijichi et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Lydia Alvarez-Erviti et al.
NATURE BIOTECHNOLOGY (2011)
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
Laura Poliseno et al.
NATURE (2010)
Context-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-Ras
Sharon Y. Gidekel Friedlander et al.
CANCER CELL (2009)
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Siddhartha Jaiswal et al.
CELL (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment
Soukaina Rejiba et al.
CANCER SCIENCE (2007)
A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites
Q Du et al.
NUCLEIC ACIDS RESEARCH (2005)
Structural basis for overhang-specific small interfering RNA recognition by the PAZ domain
JB Ma et al.
NATURE (2004)
Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59
A Clayton et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Integrin-associated protein (CD47) and its ligands
EJ Brown et al.
TRENDS IN CELL BIOLOGY (2001)
Share Paper
